150 related articles for article (PubMed ID: 28336252)
1. Trends in cervical cancer brachytherapy volume suggest case volume is not the primary driver of poor compliance rates with brachytherapy delivery for locally advanced cervical cancer.
Trifiletti DM; Grover S; Libby B; Showalter TN
Brachytherapy; 2017; 16(3):547-551. PubMed ID: 28336252
[TBL] [Abstract][Full Text] [Related]
2. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements.
Gill BS; Lin JF; Krivak TC; Sukumvanich P; Laskey RA; Ross MS; Lesnock JL; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1083-90. PubMed ID: 25216857
[TBL] [Abstract][Full Text] [Related]
3. Impact of facility volume on therapy and survival for locally advanced cervical cancer.
Lin JF; Berger JL; Krivak TC; Beriwal S; Chan JK; Sukumvanich P; Monk BJ; Richard SD
Gynecol Oncol; 2014 Feb; 132(2):416-22. PubMed ID: 24333361
[TBL] [Abstract][Full Text] [Related]
4. Patterns of radiation therapy practice for patients treated for intact cervical cancer in 2005 to 2007: a quality research in radiation oncology study.
Eifel PJ; Ho A; Khalid N; Erickson B; Owen J
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):249-56. PubMed ID: 24411621
[TBL] [Abstract][Full Text] [Related]
5. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Delivery Costs for External Beam Radiation Therapy and Brachytherapy for Locally Advanced Cervical Cancer Using Time-Driven Activity-Based Costing.
Bauer-Nilsen K; Hill C; Trifiletti DM; Libby B; Lash DH; Lain M; Christodoulou D; Hodge C; Showalter TN
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):88-94. PubMed ID: 29079120
[TBL] [Abstract][Full Text] [Related]
7. Trends in the utilization of brachytherapy in cervical cancer in the United States.
Han K; Milosevic M; Fyles A; Pintilie M; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):111-9. PubMed ID: 23849695
[TBL] [Abstract][Full Text] [Related]
8. Simulation-based graduate medical education in MR-guided brachytherapy for cervical cancer.
Singer L; McLaughlin PY; Alban G; Joyner M; King M; Lee L
Brachytherapy; 2020; 19(6):725-731. PubMed ID: 33183971
[TBL] [Abstract][Full Text] [Related]
9. Results of the 2005-2008 Association of Residents in Radiation Oncology survey of chief residents in the United States: clinical training and resident working conditions.
Gondi V; Bernard JR; Jabbari S; Keam J; de Amorim Bernstein KL; Dad LK; Li L; Poppe MM; Strauss JB; Chollet CT;
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1120-7. PubMed ID: 20932679
[TBL] [Abstract][Full Text] [Related]
10. Understanding the underutilization of cervical brachytherapy for locally advanced cervical cancer.
Ma TM; Harkenrider MM; Yashar CM; Viswanathan AN; Mayadev JS
Brachytherapy; 2019; 18(3):361-369. PubMed ID: 30723021
[TBL] [Abstract][Full Text] [Related]
11. Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a patterns of care study.
Eifel PJ; Moughan J; Erickson B; Iarocci T; Grant D; Owen J
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1144-53. PubMed ID: 15519786
[TBL] [Abstract][Full Text] [Related]
12. Prostate Brachytherapy Case Volumes by Academic and Nonacademic Practices: Implications for Future Residency Training.
Orio PF; Nguyen PL; Buzurovic I; Cail DW; Chen YW
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):624-8. PubMed ID: 27681758
[TBL] [Abstract][Full Text] [Related]
13. The decreased use of brachytherapy boost for intermediate and high-risk prostate cancer despite evidence supporting its effectiveness.
Orio PF; Nguyen PL; Buzurovic I; Cail DW; Chen YW
Brachytherapy; 2016; 15(6):701-706. PubMed ID: 27317191
[TBL] [Abstract][Full Text] [Related]
14. Influence of treatment center and hospital volume on survival for locally advanced cervical cancer.
Wright JD; Huang Y; Ananth CV; Tergas AI; Duffy C; Deutsch I; Burke WM; Hou JY; Neugut AI; Hershman DL
Gynecol Oncol; 2015 Dec; 139(3):506-12. PubMed ID: 26177552
[TBL] [Abstract][Full Text] [Related]
15. Disparities in standard of care treatment and associated survival decrement in patients with locally advanced cervical cancer.
Robin TP; Amini A; Schefter TE; Behbakht K; Fisher CM
Gynecol Oncol; 2016 Nov; 143(2):319-325. PubMed ID: 27640961
[TBL] [Abstract][Full Text] [Related]
16. Resident-reported brachytherapy experience in ACGME-accredited radiation oncology training programs.
Compton JJ; Gaspar LE; Shrieve DC; Wilson LD; Griem KL; Amdur RJ; Lee WR
Brachytherapy; 2013; 12(6):622-7. PubMed ID: 23973187
[TBL] [Abstract][Full Text] [Related]
17. External beam radiation and brachytherapy boost at different facilities is associated with increased treatment delays in cervical cancer.
Li R; Germino E; Horne ZD; Vargo JA; Chen YJ; Glaser S
Int J Gynecol Cancer; 2020 Oct; 30(10):1505-1512. PubMed ID: 32928924
[TBL] [Abstract][Full Text] [Related]
18. Proficiency-based cervical cancer brachytherapy training.
Zhao S; Francis L; Todor D; Fields EC
Brachytherapy; 2018; 17(4):653-659. PubMed ID: 29705049
[TBL] [Abstract][Full Text] [Related]
19. High versus low-dose rate brachytherapy for cervical cancer.
Patankar SS; Tergas AI; Deutsch I; Burke WM; Hou JY; Ananth CV; Huang Y; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2015 Mar; 136(3):534-41. PubMed ID: 25575481
[TBL] [Abstract][Full Text] [Related]
20. Brachytherapy should not be omitted when treating locally advanced neuroendocrine cervical cancer with definitive chemoradiation therapy.
Robin TP; Amini A; Schefter TE; Behbakht K; Fisher CM
Brachytherapy; 2016; 15(6):845-850. PubMed ID: 27720204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
